haloperidol has been researched along with Rhabdomyolysis in 17 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
Excerpt | Relevance | Reference |
---|---|---|
"A 6-year-old severely handicapped boy with haloperidol-induced mild rhabdomyolysis without neuroleptic malignant syndrome is reported." | 8.80 | Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child. ( Abe, T; Oda, Y; Ozawa, K; Watanabe, T; Yoshikawa, H, 2000) |
"BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 5.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
"Cocaine-related rhabdomyolysis has a high mortality." | 5.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
"This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 5.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
"A 6-year-old severely handicapped boy with haloperidol-induced mild rhabdomyolysis without neuroleptic malignant syndrome is reported." | 4.80 | Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child. ( Abe, T; Oda, Y; Ozawa, K; Watanabe, T; Yoshikawa, H, 2000) |
" Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
"After receiving 90 mg of haloperidol and 100 mg of chlorpromazine hydrochloride within 25 hours, a 29-year-old man was found to have neuroleptic malignant syndrome (NMS), characterized by the acute onset of hyperpyrexia, extreme muscular rigidity, autonomic instability, and coma." | 3.67 | Neuroleptic malignant syndrome and dopaminergic blockade. ( Hashimoto, F; Jeffery, WH; Sherman, CB, 1984) |
"BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 1.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
"We report a case of severe neuroleptic malignant syndrome with hyperthermia, rhabdomyolysis and hepatic failure where we applied endovascular cooling in order to reverse hyperthermia." | 1.35 | Endovascular cooling in a patient with neuroleptic malignant syndrome. ( Diedler, J; Mellado, P; Veltkamp, R, 2008) |
"Cocaine-related rhabdomyolysis has a high mortality." | 1.29 | Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? ( Daras, M; Kakkouras, L; Koppel, BS; Tuchman, AJ, 1995) |
"This case comes into the so-called neuroleptic malignant syndrome which can rarely arise in patients treated with antipsycotic agents and which causes high mortality, particularly when there are rhabdomyolysis and acute renal failure." | 1.29 | [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. ( Benati, F; Cesario, V; Lazzarin, M, 1996) |
"Rhabdomyolysis is a rarely reported complication of antipsychotic drug-induced dystonia." | 1.27 | Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs. ( Cavanaugh, JJ; Finlayson, RE, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 7 (41.18) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Takada, K | 1 |
Sada, Y | 1 |
Samura, M | 1 |
Matsuura, M | 1 |
Hirose, N | 1 |
Kurata, T | 1 |
Nagumo, F | 1 |
Ishii, J | 1 |
Koshioka, S | 1 |
Uchida, M | 1 |
Inoue, J | 1 |
Tanikawa, K | 1 |
Kunishima, H | 1 |
Kajani, R | 1 |
Apramian, A | 1 |
Vega, A | 1 |
Ubhayakar, N | 1 |
Xu, P | 1 |
Liu, A | 1 |
Wystub, N | 1 |
Heymel, S | 1 |
Fritzenwanger, M | 1 |
Schulze, PC | 1 |
Pfeifer, R | 1 |
Kamijo, Y | 1 |
Russell, T | 1 |
Riazi, S | 1 |
Kraeva, N | 1 |
Steel, AC | 1 |
Hawryluck, LA | 1 |
Diedler, J | 1 |
Mellado, P | 1 |
Veltkamp, R | 1 |
Yasukawa, M | 1 |
Hatakeyama, Y | 1 |
Yasukawa, K | 1 |
Chiba, S | 1 |
Suzuki, T | 1 |
Takami, T | 1 |
Hashimoto, F | 1 |
Sherman, CB | 1 |
Jeffery, WH | 1 |
Cavanaugh, JJ | 1 |
Finlayson, RE | 1 |
Daras, M | 1 |
Kakkouras, L | 1 |
Tuchman, AJ | 1 |
Koppel, BS | 1 |
Marsh, SJ | 1 |
Dolson, GM | 1 |
Girard, T | 1 |
Samet, S | 1 |
Bianchi-Fior, P | 1 |
Gasnault, J | 1 |
Brivet, F | 1 |
Korzets, Z | 1 |
Zelter, E | 1 |
Bernheim, J | 1 |
Lazzarin, M | 1 |
Benati, F | 1 |
Cesario, V | 1 |
Seki, Y | 1 |
Takahashi, H | 1 |
Aizawa, Y | 1 |
Yoshikawa, H | 1 |
Watanabe, T | 1 |
Abe, T | 1 |
Oda, Y | 1 |
Ozawa, K | 1 |
Soejima, A | 1 |
Suzuki, M | 1 |
Nagasawa, T | 1 |
3 reviews available for haloperidol and Rhabdomyolysis
Article | Year |
---|---|
[Dangerous drugs: products containing synthetic chemicals].
Topics: Alkaloids; Antipsychotic Agents; Cannabinoids; Central Nervous System Diseases; Consciousness Disord | 2016 |
Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.
Topics: Anti-Dyskinesia Agents; Child; Disabled Persons; Haloperidol; Humans; Male; Movement Disorders; Neur | 2000 |
[Rhabdomyolysis].
Topics: Acute Kidney Injury; Adult; Chlorpromazine; Female; Haloperidol; Humans; Myoglobin; Myoglobinuria; R | 1991 |
14 other studies available for haloperidol and Rhabdomyolysis
Article | Year |
---|---|
A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.
Topics: Acute Kidney Injury; COVID-19; Haloperidol; Hematuria; Humans; Male; Middle Aged; Rhabdomyolysis | 2022 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Topics: Antipsychotic Agents; Dantrolene; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Synd | 2018 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Endovascular cooling in a patient with neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Catheters, Indwelling; Creatine Kinase; Drug Synergism; Female; Fever; Haloper | 2008 |
[Neuroleptic malignant syndrome with myoglobinuria].
Topics: Basal Ganglia Diseases; Female; Haloperidol; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis; Sch | 1983 |
Neuroleptic malignant syndrome and dopaminergic blockade.
Topics: Adult; Chlorpromazine; Dopamine; Haloperidol; Humans; Male; Muscular Diseases; Receptors, Dopamine; | 1984 |
Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs.
Topics: Acute Disease; Adult; Dystonia; Haloperidol; Humans; Male; Muscles; Myoglobinuria; Psychotic Disorde | 1984 |
Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?
Topics: Adult; Antipsychotic Agents; Brain; Cell Death; Cocaine; Diagnosis, Differential; Diazepam; Female; | 1995 |
Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant S | 1995 |
[Haloperidol, a new cause of rhabdomyolysis, in the absence of neuroleptic malignant syndrome].
Topics: Aged; Haloperidol; Humans; Male; Rhabdomyolysis | 1994 |
Acute renal failure in the setting of the neuroleptic malignant syndrome.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine Antagonists; Female; Ha | 1996 |
[Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
Topics: Acute Kidney Injury; Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malig | 1996 |
[Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Blood Coagulation; Blood Coagula | 1998 |